If this is your company, CONTACT US to activate Packbase™ software to build your portal.

    Webpackaging logo

    Nemera’s preservative-free multidose eye dropper Novelia approved for Santen’s Cosopt for Glaucoma treatments

    Quick Contact
    Nemera’s preservative-free multidose eye dropper Novelia approved for Santen’s Cosopt for Glaucoma treatments

    • Europe

    • Asia

    • East Asia

    • China

    • Health

    • Pharmaceuticals

    • Primary Packaging

    • Bottles

    • Dispensing Closures

    • Bulbs, Pipettes, Droppers

    • Shows, Associations, Media

    • Packaging Trade Shows, Events

    Europe, Asia, East Asia, China, Health, Pharmaceuticals, Primary Packaging, Bottles, Dispensing Closures, Bulbs, Pipettes, Droppers, Shows, Associations, Media, Packaging Trade Shows, Events

    Nemera’s multidose eye dropper Novelia® has been approved for the preservative-free formulation Cosopt iMulti®

    There is an innovation in glaucoma management by providing preservative-free medicines in multi-dose bottles to allow for effective and convenient, 24-hour intraocular pressure (IOP) control to glaucoma patients aged 18 or over.

    “We are delighted to launch preservative-free multi-dose formulations of these glaucoma therapies in Europe,” said Luis Iglesias, Corporate Officer and Head of EMEA, Santen. “By providing highly effective and well-tolerated, preservative-free medicines, with the option for multi-dose bottles, we hope to empower patients in their daily lives and improve the management of their condition.”

    “Patient adherence is the key for success for all treatments, especially silent chronic ophthalmic diseases. This is why, at Nemera, we developed an innovative system combining all patient needs: a safe preservative-free multi-dose bottle with a blue tip that makes consistent drops one by one” commented Fanny Sellier, Global Category Manager for Ophthalmic Products, Nemera.

    The importance of preservative-free

    The European Medicines Agency (EMA) outlines that preservatives should be avoided in patients who are on long-term treatment, or do not tolerate preserved eye drops.

    Switching from preserved to preservative-free topical ocular medications can diminish the harmful effects caused by preservatives. For example, switching to Cosopt preservative-free improved local ocular tolerability for 85% of patients compared with their previous preserved medication

    Key benefits of Novelia

    • 100% controlled and safe thanks to its patented PureFlow® Technology
    • Works with high viscosity suspensions, emulsions and solutions up to 1500cps
    • User-friendly and intuitive: easy eye targeting thanks to its blue tip feature, as easy to use as any standard eyedropper
    • One drop at a time into the patient’s eye
    • Calibrated drops providing a precise dose for a better treatment adherence

    Novelia will also be shown at differents events in the next months: Interphex, ARVO, FCE Pharma, CPhI China and CPhI Worldwide.

    • Brand Launch
    • English
    • Modified 15 Apr 2019
    • Hits 3703